SGA
SGMO

Sector Gamma AS’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Sector Gamma AS’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-211,698
Closed -$1.77M – 36
2019
Q4 		$1.77M Sell
211,698
-40,000
-16% -$368K 0.28% 36
2019
Q3 		$2.28M Hold
251,698
– – 0.38% 33
2019
Q2 		$2.71M Buy
251,698
+12,841
+5% +$137K 0.44% 34
2019
Q1 		$2.28M Buy
238,857
+83,897
+54% +$857K 0.37% 32
2018
Q4 		$1.78M Hold
154,960
– – 0.3% 32
2018
Q3 		$2.63M Buy
154,960
+8,960
+6% +$136K 0.41% 28
2018
Q2 		$2.07M Buy
146,000
+50,000
+52% +$831K 0.34% 31
2018
Q1 		$1.82M Buy
+96,000
New +$2.05M 0.33% 30

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sector Gamma AS's SGMO Position: Q1 2020 in Review

Sector Gamma AS sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 211,698 shares — an estimated $1.77M sold.

Sector Gamma AS first reported a position in SGMO in Q1 2018 and held it in 8 quarters. The position peaked at $2.71M in Q2 2019. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

  • Sector Gamma AS reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
  • Sector Gamma AS sold 211,698 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $1.77M.
  • Sector Gamma AS first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 8 quarters.
  • Sector Gamma AS's SANGAMO THERAPEUTICS INC position peaked at $2.71M in Q2 2019.
  • 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on Sector Gamma AS's 13F filing for Q1 2020, filed 11 May 2020.